APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-PD-1 Antibody

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Anti-PD-1 Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025195 pages

Choose your research edition.

Industry ResearchAnti-PD-1 Antibody Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-PD-1 Antibody Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Anti-PD-1 Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-PD-1 Antibody Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-PD-1 Antibody Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Anti-PD-1 Antibody market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Anti-PD-1 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Anti-PD-1 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-PD-1 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Anti-PD-1 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anti-PD-1 Antibody include 3SBio Inc, Thermo Fisher, Novartis, Merck, Lilly, Sino Biological Inc, Bristol-Myers Squibb (BMS), Abcam and Abbvie, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Anti-PD-1 Antibody market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Anti-PD-1 Antibody and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Anti-PD-1 Antibody sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Anti-PD-1 Antibody market size, projected growth trends, production technologies, key applications, and end-use industries.

Anti-PD-1 Antibody Segment by Company

3SBio Inc

Thermo Fisher

Novartis

Merck

Lilly

Sino Biological Inc

Bristol-Myers Squibb (BMS)

Abcam

Abbvie

TG Therapeutics, Inc

Ono Pharmaceutical Co., Ltd

InvivoGen

Chugai Pharmaceutical Co., Ltd

BioVision Inc

Bio X Cell

BeiGene

Arcus Biosciences

Anti-PD-1 Antibody Segment by Type

Monoclonal

Polyclonal

Anti-PD-1 Antibody Segment by Application

IHC-P

ICC/IF

ELISA

Flow Cytometry

WB

Anti-PD-1 Antibody Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-PD-1 Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-PD-1 Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-PD-1 Antibody.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Anti-PD-1 Antibody market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anti-PD-1 Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Anti-PD-1 Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Anti-PD-1 Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Anti-PD-1 Antibody Industry Trends Table 2. Anti-PD-1 Antibody Industry Drivers Table 3. Anti-PD-1 Antibody Industry Opportunities and Challenges Table 4. Anti-PD-1 Antibody Industry Restraints Table 5. Global Anti-PD-1 Antibody Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Anti-PD-1 Antibody Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Anti-PD-1 Antibody Sales by Manufacturers (kg) & (2021-2026) Table 8. Global Anti-PD-1 Antibody Sales Market Share by Manufacturers Table 9. Global Anti-PD-1 Antibody Average Sales Price (US$/g) of Manufacturers (2021-2026) Table 10. Global Anti-PD-1 Antibody Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Anti-PD-1 Antibody Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Anti-PD-1 Antibody Manufacturers, Product Type & Application Table 13. Global Anti-PD-1 Antibody Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Anti-PD-1 Antibody by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Monoclonal Table 17. Major Manufacturers of Polyclonal Table 18. Global Anti-PD-1 Antibody Sales by Type 2021 VS 2025 VS 2032 (kg) Table 19. Global Anti-PD-1 Antibody Sales by Type (2021-2026) & (kg) Table 20. Global Anti-PD-1 Antibody Sales by Type (2027-2032) & (kg) Table 21. Global Anti-PD-1 Antibody Sales Market Share by Type (2021-2026) Table 22. Global Anti-PD-1 Antibody Sales Market Share by Type (2027-2032) Table 23. Global Anti-PD-1 Antibody Revenue by Type 2021 VS 2025 VS 2032 (kg) Table 24. Global Anti-PD-1 Antibody Revenue by Type (2021-2026) & (kg) Table 25. Global Anti-PD-1 Antibody Revenue by Type (2027-2032) & (kg) Table 26. Global Anti-PD-1 Antibody Revenue Market Share by Type (2021-2026) Table 27. Global Anti-PD-1 Antibody Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of IHC-P Table 29. Major Manufacturers of ICC/IF Table 30. Major Manufacturers of ELISA Table 31. Major Manufacturers of Flow Cytometry Table 32. Major Manufacturers of WB Table 33. Global Anti-PD-1 Antibody Sales by Application 2021 VS 2025 VS 2032 (kg) Table 34. Global Anti-PD-1 Antibody Sales by Application (2021-2026) & (kg) Table 35. Global Anti-PD-1 Antibody Sales by Application (2027-2032) & (kg) Table 36. Global Anti-PD-1 Antibody Sales Market Share by Application (2021-2026) Table 37. Global Anti-PD-1 Antibody Sales Market Share by Application (2027-2032) Table 38. Global Anti-PD-1 Antibody Revenue by Application 2021 VS 2025 VS 2032 (kg) Table 39. Global Anti-PD-1 Antibody Revenue by Application (2021-2026) & (kg) Table 40. Global Anti-PD-1 Antibody Revenue by Application (2027-2032) & (kg) Table 41. Global Anti-PD-1 Antibody Revenue Market Share by Application (2021-2026) Table 42. Global Anti-PD-1 Antibody Revenue Market Share by Application (2027-2032) Table 43. Global Anti-PD-1 Antibody Sales by Region: 2021 VS 2025 VS 2032 (kg) Table 44. Global Anti-PD-1 Antibody Sales by Region (2021-2026) & (kg) Table 45. Global Anti-PD-1 Antibody Sales Market Share by Region (2021-2026) Table 46. Global Anti-PD-1 Antibody Sales Forecasted by Region (2027-2032) & (kg) Table 47. Global Anti-PD-1 Antibody Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Anti-PD-1 Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kg) Table 49. North America Anti-PD-1 Antibody Sales by Country (2021-2026) & (kg) Table 50. North America Anti-PD-1 Antibody Sales by Country (2027-2032) & (kg) Table 51. Europe Anti-PD-1 Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kg) Table 52. Europe Anti-PD-1 Antibody Sales by Country (2021-2026) & (kg) Table 53. Europe Anti-PD-1 Antibody Sales by Country (2027-2032) & (kg) Table 54. Asia Pacific Anti-PD-1 Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kg) Table 55. Asia Pacific Anti-PD-1 Antibody Sales by Country (2021-2026) & (kg) Table 56. Asia Pacific Anti-PD-1 Antibody Sales by Country (2027-2032) & (kg) Table 57. South America, Middle East and Africa Anti-PD-1 Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kg) Table 58. South America, Middle East and Africa Anti-PD-1 Antibody Sales by Country (2021-2026) & (kg) Table 59. South America, Middle East and Africa Anti-PD-1 Antibody Sales by Country (2027-2032) & (kg) Table 60. Global Anti-PD-1 Antibody Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Anti-PD-1 Antibody Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Anti-PD-1 Antibody Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Anti-PD-1 Antibody Revenue Market Share by Region (2021-2026) Table 64. Global Anti-PD-1 Antibody Revenue Market Share by Region (2027-2032) Table 65. 3SBio Inc Company Information Table 66. 3SBio Inc Business Overview Table 67. 3SBio Inc Anti-PD-1 Antibody Sales (kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. 3SBio Inc Anti-PD-1 Antibody Product Portfolio Table 69. 3SBio Inc Recent Development Table 70. Thermo Fisher Company Information Table 71. Thermo Fisher Business Overview Table 72. Thermo Fisher Anti-PD-1 Antibody Sales (kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Thermo Fisher Anti-PD-1 Antibody Product Portfolio Table 74. Thermo Fisher Recent Development Table 75. Novartis Company Information Table 76. Novartis Business Overview Table 77. Novartis Anti-PD-1 Antibody Sales (kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Novartis Anti-PD-1 Antibody Product Portfolio Table 79. Novartis Recent Development Table 80. Merck Company Information Table 81. Merck Business Overview Table 82. Merck Anti-PD-1 Antibody Sales (kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Merck Anti-PD-1 Antibody Product Portfolio Table 84. Merck Recent Development Table 85. Lilly Company Information Table 86. Lilly Business Overview Table 87. Lilly Anti-PD-1 Antibody Sales (kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Lilly Anti-PD-1 Antibody Product Portfolio Table 89. Lilly Recent Development Table 90. Sino Biological Inc Company Information Table 91. Sino Biological Inc Business Overview Table 92. Sino Biological Inc Anti-PD-1 Antibody Sales (kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Sino Biological Inc Anti-PD-1 Antibody Product Portfolio Table 94. Sino Biological Inc Recent Development Table 95. Bristol-Myers Squibb (BMS) Company Information Table 96. Bristol-Myers Squibb (BMS) Business Overview Table 97. Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Sales (kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Product Portfolio Table 99. Bristol-Myers Squibb (BMS) Recent Development Table 100. Abcam Company Information Table 101. Abcam Business Overview Table 102. Abcam Anti-PD-1 Antibody Sales (kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Abcam Anti-PD-1 Antibody Product Portfolio Table 104. Abcam Recent Development Table 105. Abbvie Company Information Table 106. Abbvie Business Overview Table 107. Abbvie Anti-PD-1 Antibody Sales (kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Abbvie Anti-PD-1 Antibody Product Portfolio Table 109. Abbvie Recent Development Table 110. TG Therapeutics, Inc Company Information Table 111. TG Therapeutics, Inc Business Overview Table 112. TG Therapeutics, Inc Anti-PD-1 Antibody Sales (kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. TG Therapeutics, Inc Anti-PD-1 Antibody Product Portfolio Table 114. TG Therapeutics, Inc Recent Development Table 115. Ono Pharmaceutical Co., Ltd Company Information Table 116. Ono Pharmaceutical Co., Ltd Business Overview Table 117. Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales (kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Product Portfolio Table 119. Ono Pharmaceutical Co., Ltd Recent Development Table 120. InvivoGen Company Information Table 121. InvivoGen Business Overview Table 122. InvivoGen Anti-PD-1 Antibody Sales (kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. InvivoGen Anti-PD-1 Antibody Product Portfolio Table 124. InvivoGen Recent Development Table 125. Chugai Pharmaceutical Co., Ltd Company Information Table 126. Chugai Pharmaceutical Co., Ltd Business Overview Table 127. Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales (kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Product Portfolio Table 129. Chugai Pharmaceutical Co., Ltd Recent Development Table 130. BioVision Inc Company Information Table 131. BioVision Inc Business Overview Table 132. BioVision Inc Anti-PD-1 Antibody Sales (kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. BioVision Inc Anti-PD-1 Antibody Product Portfolio Table 134. BioVision Inc Recent Development Table 135. Bio X Cell Company Information Table 136. Bio X Cell Business Overview Table 137. Bio X Cell Anti-PD-1 Antibody Sales (kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. Bio X Cell Anti-PD-1 Antibody Product Portfolio Table 139. Bio X Cell Recent Development Table 140. BeiGene Company Information Table 141. BeiGene Business Overview Table 142. BeiGene Anti-PD-1 Antibody Sales (kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 143. BeiGene Anti-PD-1 Antibody Product Portfolio Table 144. BeiGene Recent Development Table 145. Arcus Biosciences Company Information Table 146. Arcus Biosciences Business Overview Table 147. Arcus Biosciences Anti-PD-1 Antibody Sales (kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 148. Arcus Biosciences Anti-PD-1 Antibody Product Portfolio Table 149. Arcus Biosciences Recent Development Table 150. Key Raw Materials Table 151. Raw Materials Key Suppliers Table 152. Anti-PD-1 Antibody Distributors List Table 153. Anti-PD-1 Antibody Customers List Table 154. Research Programs/Design for This Report Table 155. Authors List of This Report Table 156. Secondary Sources Table 157. Primary Sources List of Figures Figure 1. Anti-PD-1 Antibody Product Image Figure 2. Global Anti-PD-1 Antibody Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-PD-1 Antibody Market Size (2021-2032) & (US$ Million) Figure 4. Global Anti-PD-1 Antibody Sales (2021-2032) & (kg) Figure 5. Global Anti-PD-1 Antibody Average Price (US$/g) & (2021-2032) Figure 6. Global Top 5 and 10 Anti-PD-1 Antibody Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Monoclonal Image Figure 9. Polyclonal Image Figure 10. Global Anti-PD-1 Antibody Sales by Type (2021 VS 2025 VS 2032) & (kg) Figure 11. Global Anti-PD-1 Antibody Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Anti-PD-1 Antibody Sales Market Share by Type (2021-2032) Figure 13. Global Anti-PD-1 Antibody Revenue by Type (2021 VS 2025 VS 2032) & (kg) Figure 14. Global Anti-PD-1 Antibody Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Anti-PD-1 Antibody Revenue Market Share by Type (2021-2032) Figure 16. IHC-P Image Figure 17. ICC/IF Image Figure 18. ELISA Image Figure 19. Flow Cytometry Image Figure 20. WB Image Figure 21. Global Anti-PD-1 Antibody Sales by Application (2021 VS 2025 VS 2032) & (kg) Figure 22. Global Anti-PD-1 Antibody Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Anti-PD-1 Antibody Sales Market Share by Application (2021-2032) Figure 24. Global Anti-PD-1 Antibody Revenue by Application (2021 VS 2025 VS 2032) & (kg) Figure 25. Global Anti-PD-1 Antibody Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Anti-PD-1 Antibody Revenue Market Share by Application (2021-2032) Figure 27. North America Anti-PD-1 Antibody Sales and Growth Rate (2021-2032) & (kg) Figure 28. North America Anti-PD-1 Antibody Sales Market Share by Country (2021-2032) Figure 29. U.S. Anti-PD-1 Antibody Sales and Growth Rate (2021-2032) & (kg) Figure 30. Canada Anti-PD-1 Antibody Sales and Growth Rate (2021-2032) & (kg) Figure 31. Mexico Anti-PD-1 Antibody Sales and Growth Rate (2021-2032) & (kg) Figure 32. Europe Anti-PD-1 Antibody Sales and Growth Rate (2021-2032) & (kg) Figure 33. Europe Anti-PD-1 Antibody Sales Market Share by Country (2021-2032) Figure 34. Germany Anti-PD-1 Antibody Sales and Growth Rate (2021-2032) & (kg) Figure 35. France Anti-PD-1 Antibody Sales and Growth Rate (2021-2032) & (kg) Figure 36. U.K. Anti-PD-1 Antibody Sales and Growth Rate (2021-2032) & (kg) Figure 37. Italy Anti-PD-1 Antibody Sales and Growth Rate (2021-2032) & (kg) Figure 38. Netherlands Anti-PD-1 Antibody Sales and Growth Rate (2021-2032) & (kg) Figure 39. Asia Pacific Anti-PD-1 Antibody Sales and Growth Rate (2021-2032) & (kg) Figure 40. Asia Pacific Anti-PD-1 Antibody Sales Market Share by Country (2021-2032) Figure 41. China Anti-PD-1 Antibody Sales and Growth Rate (2021-2032) & (kg) Figure 42. Japan Anti-PD-1 Antibody Sales and Growth Rate (2021-2032) & (kg) Figure 43. South Korea Anti-PD-1 Antibody Sales and Growth Rate (2021-2032) & (kg) Figure 44. Southeast Asia Anti-PD-1 Antibody Sales and Growth Rate (2021-2032) & (kg) Figure 45. India Anti-PD-1 Antibody Sales and Growth Rate (2021-2032) & (kg) Figure 46. Australia Anti-PD-1 Antibody Sales and Growth Rate (2021-2032) & (kg) Figure 47. South America, Middle East and Africa Anti-PD-1 Antibody Sales and Growth Rate (2021-2032) & (kg) Figure 48. South America, Middle East and Africa Anti-PD-1 Antibody Sales Market Share by Country (2021-2032) Figure 49. Brazil Anti-PD-1 Antibody Sales and Growth Rate (2021-2032) & (kg) Figure 50. South Africa Anti-PD-1 Antibody Sales and Growth Rate (2021-2032) & (kg) Figure 51. Saudi Arabia Anti-PD-1 Antibody Sales and Growth Rate (2021-2032) & (kg) Figure 52. Turkey Anti-PD-1 Antibody Sales and Growth Rate (2021-2032) & (kg) Figure 53. Argentina Anti-PD-1 Antibody Sales and Growth Rate (2021-2032) & (kg) Figure 54. UAE Anti-PD-1 Antibody Sales and Growth Rate (2021-2032) & (kg) Figure 55. Egypt Anti-PD-1 Antibody Sales and Growth Rate (2021-2032) & (kg) Figure 56. Chile Anti-PD-1 Antibody Sales and Growth Rate (2021-2032) & (kg) Figure 57. Global Anti-PD-1 Antibody Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Anti-PD-1 Antibody Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Anti-PD-1 Antibody Revenue (2021-2032) & (US$ Million) Figure 60. North America Anti-PD-1 Antibody Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Anti-PD-1 Antibody Revenue (2021-2032) & (US$ Million) Figure 62. Europe Anti-PD-1 Antibody Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Anti-PD-1 Antibody Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Anti-PD-1 Antibody Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Anti-PD-1 Antibody Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Anti-PD-1 Antibody Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Anti-PD-1 Antibody Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Anti-PD-1 Antibody Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Monoclonal
  • Polyclonal
Applications
  • IHC-P
  • ICC/IF
  • ELISA
  • Flow Cytometry
  • WB
Companies covered
  • 3SBio Inc
  • Thermo Fisher
  • Novartis
  • Merck
  • Lilly
  • Sino Biological Inc
  • Bristol-Myers Squibb (BMS)
  • Abcam
  • Abbvie
  • TG Therapeutics, Inc
  • Ono Pharmaceutical Co., Ltd
  • InvivoGen
  • Chugai Pharmaceutical Co., Ltd
  • BioVision Inc
  • Bio X Cell
  • BeiGene
  • Arcus Biosciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Anti-PD-1 Antibody Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Anti-PD-1 Antibody Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Anti-PD-1 Antibody Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Anti-PD-1 Antibody Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Anti-PD-1 Antibody Market Dynamics
  1. 2.1 Anti-PD-1 Antibody Industry Trends
  2. 2.2 Anti-PD-1 Antibody Industry Drivers
  3. 2.3 Anti-PD-1 Antibody Industry Opportunities and Challenges
  4. 2.4 Anti-PD-1 Antibody Industry Restraints
3 Anti-PD-1 Antibody Market by Manufacturers
  1. 3.1 Global Anti-PD-1 Antibody Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Anti-PD-1 Antibody Sales by Manufacturers (2021-2026)
  3. 3.3 Global Anti-PD-1 Antibody Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Anti-PD-1 Antibody Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anti-PD-1 Antibody Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Anti-PD-1 Antibody Manufacturers, Product Type & Application
  7. 3.7 Global Anti-PD-1 Antibody Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anti-PD-1 Antibody Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anti-PD-1 Antibody Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anti-PD-1 Antibody Tier 1, Tier 2, and Tier 3
4 Anti-PD-1 Antibody Market by Type
  1. 4.1 Anti-PD-1 Antibody Type Introduction
  2. 4.1.1 Monoclonal
  3. 4.1.2 Polyclonal
  4. 4.2 Global Anti-PD-1 Antibody Sales by Type
  5. 4.2.1 Global Anti-PD-1 Antibody Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Anti-PD-1 Antibody Sales by Type (2021-2032)
  7. 4.2.3 Global Anti-PD-1 Antibody Sales Market Share by Type (2021-2032)
  8. 4.3 Global Anti-PD-1 Antibody Revenue by Type
  9. 4.3.1 Global Anti-PD-1 Antibody Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Anti-PD-1 Antibody Revenue by Type (2021-2032)
  11. 4.3.3 Global Anti-PD-1 Antibody Revenue Market Share by Type (2021-2032)
5 Anti-PD-1 Antibody Market by Application
  1. 5.1 Anti-PD-1 Antibody Application Introduction
  2. 5.1.1 IHC-P
  3. 5.1.2 ICC/IF
  4. 5.1.3 ELISA
  5. 5.1.4 Flow Cytometry
  6. 5.1.5 WB
  7. 5.2 Global Anti-PD-1 Antibody Sales by Application
  8. 5.2.1 Global Anti-PD-1 Antibody Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Anti-PD-1 Antibody Sales by Application (2021-2032)
  10. 5.2.3 Global Anti-PD-1 Antibody Sales Market Share by Application (2021-2032)
  11. 5.3 Global Anti-PD-1 Antibody Revenue by Application
  12. 5.3.1 Global Anti-PD-1 Antibody Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Anti-PD-1 Antibody Revenue by Application (2021-2032)
  14. 5.3.3 Global Anti-PD-1 Antibody Revenue Market Share by Application (2021-2032)
6 Global Anti-PD-1 Antibody Sales by Region
  1. 6.1 Global Anti-PD-1 Antibody Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Anti-PD-1 Antibody Sales by Region (2021-2032)
  3. 6.2.1 Global Anti-PD-1 Antibody Sales by Region (2021-2026)
  4. 6.2.2 Global Anti-PD-1 Antibody Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Anti-PD-1 Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Anti-PD-1 Antibody Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Anti-PD-1 Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Anti-PD-1 Antibody Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Anti-PD-1 Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Anti-PD-1 Antibody Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Anti-PD-1 Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Anti-PD-1 Antibody Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Anti-PD-1 Antibody Revenue by Region
  1. 7.1 Global Anti-PD-1 Antibody Revenue by Region
  2. 7.1.1 Global Anti-PD-1 Antibody Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Anti-PD-1 Antibody Revenue by Region (2021-2026)
  4. 7.1.3 Global Anti-PD-1 Antibody Revenue by Region (2027-2032)
  5. 7.1.4 Global Anti-PD-1 Antibody Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Anti-PD-1 Antibody Revenue (2021-2032)
  8. 7.2.2 North America Anti-PD-1 Antibody Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Anti-PD-1 Antibody Revenue (2021-2032)
  11. 7.3.2 Europe Anti-PD-1 Antibody Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Anti-PD-1 Antibody Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Anti-PD-1 Antibody Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Anti-PD-1 Antibody Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Anti-PD-1 Antibody Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 3SBio Inc
  2. 8.1.1 3SBio Inc Company Information
  3. 8.1.2 3SBio Inc Business Overview
  4. 8.1.3 3SBio Inc Anti-PD-1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 3SBio Inc Anti-PD-1 Antibody Product Portfolio
  6. 8.1.5 3SBio Inc Recent Developments
  7. 8.2 Thermo Fisher
  8. 8.2.1 Thermo Fisher Company Information
  9. 8.2.2 Thermo Fisher Business Overview
  10. 8.2.3 Thermo Fisher Anti-PD-1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Thermo Fisher Anti-PD-1 Antibody Product Portfolio
  12. 8.2.5 Thermo Fisher Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Anti-PD-1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Anti-PD-1 Antibody Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 Merck
  20. 8.4.1 Merck Company Information
  21. 8.4.2 Merck Business Overview
  22. 8.4.3 Merck Anti-PD-1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Merck Anti-PD-1 Antibody Product Portfolio
  24. 8.4.5 Merck Recent Developments
  25. 8.5 Lilly
  26. 8.5.1 Lilly Company Information
  27. 8.5.2 Lilly Business Overview
  28. 8.5.3 Lilly Anti-PD-1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Lilly Anti-PD-1 Antibody Product Portfolio
  30. 8.5.5 Lilly Recent Developments
  31. 8.6 Sino Biological Inc
  32. 8.6.1 Sino Biological Inc Company Information
  33. 8.6.2 Sino Biological Inc Business Overview
  34. 8.6.3 Sino Biological Inc Anti-PD-1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sino Biological Inc Anti-PD-1 Antibody Product Portfolio
  36. 8.6.5 Sino Biological Inc Recent Developments
  37. 8.7 Bristol-Myers Squibb (BMS)
  38. 8.7.1 Bristol-Myers Squibb (BMS) Company Information
  39. 8.7.2 Bristol-Myers Squibb (BMS) Business Overview
  40. 8.7.3 Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Product Portfolio
  42. 8.7.5 Bristol-Myers Squibb (BMS) Recent Developments
  43. 8.8 Abcam
  44. 8.8.1 Abcam Company Information
  45. 8.8.2 Abcam Business Overview
  46. 8.8.3 Abcam Anti-PD-1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Abcam Anti-PD-1 Antibody Product Portfolio
  48. 8.8.5 Abcam Recent Developments
  49. 8.9 Abbvie
  50. 8.9.1 Abbvie Company Information
  51. 8.9.2 Abbvie Business Overview
  52. 8.9.3 Abbvie Anti-PD-1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Abbvie Anti-PD-1 Antibody Product Portfolio
  54. 8.9.5 Abbvie Recent Developments
  55. 8.10 TG Therapeutics, Inc
  56. 8.10.1 TG Therapeutics, Inc Company Information
  57. 8.10.2 TG Therapeutics, Inc Business Overview
  58. 8.10.3 TG Therapeutics, Inc Anti-PD-1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 TG Therapeutics, Inc Anti-PD-1 Antibody Product Portfolio
  60. 8.10.5 TG Therapeutics, Inc Recent Developments
  61. 8.11 Ono Pharmaceutical Co., Ltd
  62. 8.11.1 Ono Pharmaceutical Co., Ltd Company Information
  63. 8.11.2 Ono Pharmaceutical Co., Ltd Business Overview
  64. 8.11.3 Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Product Portfolio
  66. 8.11.5 Ono Pharmaceutical Co., Ltd Recent Developments
  67. 8.12 InvivoGen
  68. 8.12.1 InvivoGen Company Information
  69. 8.12.2 InvivoGen Business Overview
  70. 8.12.3 InvivoGen Anti-PD-1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 InvivoGen Anti-PD-1 Antibody Product Portfolio
  72. 8.12.5 InvivoGen Recent Developments
  73. 8.13 Chugai Pharmaceutical Co., Ltd
  74. 8.13.1 Chugai Pharmaceutical Co., Ltd Company Information
  75. 8.13.2 Chugai Pharmaceutical Co., Ltd Business Overview
  76. 8.13.3 Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Product Portfolio
  78. 8.13.5 Chugai Pharmaceutical Co., Ltd Recent Developments
  79. 8.14 BioVision Inc
  80. 8.14.1 BioVision Inc Company Information
  81. 8.14.2 BioVision Inc Business Overview
  82. 8.14.3 BioVision Inc Anti-PD-1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 BioVision Inc Anti-PD-1 Antibody Product Portfolio
  84. 8.14.5 BioVision Inc Recent Developments
  85. 8.15 Bio X Cell
  86. 8.15.1 Bio X Cell Company Information
  87. 8.15.2 Bio X Cell Business Overview
  88. 8.15.3 Bio X Cell Anti-PD-1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Bio X Cell Anti-PD-1 Antibody Product Portfolio
  90. 8.15.5 Bio X Cell Recent Developments
  91. 8.16 BeiGene
  92. 8.16.1 BeiGene Company Information
  93. 8.16.2 BeiGene Business Overview
  94. 8.16.3 BeiGene Anti-PD-1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 BeiGene Anti-PD-1 Antibody Product Portfolio
  96. 8.16.5 BeiGene Recent Developments
  97. 8.17 Arcus Biosciences
  98. 8.17.1 Arcus Biosciences Company Information
  99. 8.17.2 Arcus Biosciences Business Overview
  100. 8.17.3 Arcus Biosciences Anti-PD-1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Arcus Biosciences Anti-PD-1 Antibody Product Portfolio
  102. 8.17.5 Arcus Biosciences Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Anti-PD-1 Antibody Value Chain Analysis
  2. 9.1.1 Anti-PD-1 Antibody Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Anti-PD-1 Antibody Production Mode & Process
  6. 9.2 Anti-PD-1 Antibody Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Anti-PD-1 Antibody Distributors
  9. 9.2.3 Anti-PD-1 Antibody Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst